Data Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant Therapy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Carcinoma
- Sponsor
- SPGO Research Mannheim GmbH
- Enrollment
- 2000
- Locations
- 1
- Primary Endpoint
- Anti-cancer treatments (Course of the disease and type of applied anti-cancer therapies. Assessment of guidelines' implementation)
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this registry is to evaluate the situation regarding ambulant therapy of cancer patients in different practices in Germany. It should provide insight into the implementation of schemes for cancer therapy predefined in the guidelines, the treatment of diverse adverse reactions and the counter measures taken. Thereby, potential differences in treatment and with that differences in quality amongst individual practices might be identified. The medium to long term aim is to contribute to positively influence the quality of medical care of cancer patients in Germany.
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 years and older
- •Tumor disease (carcinoma of either breast, ovary, lung, colon, stomach, pancreas, rectum or plasmacytoma)
- •Written informed consent
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Anti-cancer treatments (Course of the disease and type of applied anti-cancer therapies. Assessment of guidelines' implementation)
Time Frame: From date of ICF until date of cure/death/ICF withdrawal, up to 60 months
Course of the disease and type of applied anti-cancer therapies. Assessment of guidelines' implementation
Secondary Outcomes
- Adverse reactions and their treatment (Number and type of adverse reactions and applied counter measures / therapies)(From date of ICF until date of cure/death/ICF withdrawal, up to 60 months)